Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04062305 · ClinicalTrials.gov registry record · NA
nTMS in Planning Stereotactic Radiosurgery in Patients With Brain Metastases in the Motor Cortex
A NA study of Metastatic Malignant Neoplasm in the Brain and Radiation Therapy Recipient, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT04062305 is a NA study of Metastatic Malignant Neoplasm in the Brain and Radiation Therapy Recipient that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 22 participants, below the 88-participant average among 43 other Metastatic Malignant Neoplasm in the Brain trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04062305, a NA study of Metastatic Malignant Neoplasm in the Brain and Radiation Therapy Recipient, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how well nTMS works in planning for stereotactic radiosurgery in patients with brain metastases in the motor cortex. Stereotactic radiosurgery is a type of radiation therapy that delivers high doses of radiation, which can sometimes lead to damage occurring to the brain and surrounding areas. The motor cortex (the part of the nervous system that controls muscle movement), however, currently has no radiation dose limit. nTMS is a non-invasive tool that uses sensors on a patient's muscle to trace the location in their brain that controls that muscle and is currently used by doctors to decide where to operate so as not to damage the motor nerves. nTMS may effectively help plan radiation treatment using SRS and help doctors decide on how much radiation can be used on motor nerves.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- BEHAVIORAL Hand Function Test
- PROCEDURE Navigated Transcranial Magnetic Stimulation
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-09-09 |
| Est. Completion | 2027-05-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04062305
The ClinicalTrials.gov registry entry for NCT04062305 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 88-participant average among 43 other Metastatic Malignant Neoplasm in the Brain trials with a reported enrollment target (75% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Metastatic Malignant Neoplasm in the Brain appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04062305 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04062305 about?
NCT04062305 is a clinical study titled "nTMS in Planning Stereotactic Radiosurgery in Patients With Brain Metastases in the Motor Cortex". This trial studies how well nTMS works in planning for stereotactic radiosurgery in patients with brain metastases in the motor cortex. Stereotactic radiosurgery is a type of radiation therapy that delivers high doses of radiation, which can sometimes lead to damage occurring to the brain and surrou...
What is the current status of trial NCT04062305?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2019-09-09. Estimated completion is 2027-05-06.
What conditions does trial NCT04062305 study?
This clinical trial studies the following conditions: Metastatic Malignant Neoplasm in the Brain, Radiation Therapy Recipient.
What interventions are being tested in trial NCT04062305?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Hand Function Test (BEHAVIORAL), Navigated Transcranial Magnetic Stimulation (PROCEDURE).
Who is sponsoring clinical trial NCT04062305?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04062305 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Malignant Neoplasm in the Brain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
RECRUITING · NA
-
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
RECRUITING · NA
-
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
RECRUITING · NA
-
Feasibility of Intraoperative Microdialysis During Neurosurgery for Central Nervous System Malignancies
RECRUITING · NA
-
Mind-Body Intervention in Glioma Couples
ACTIVE NOT RECRUITING · NA
-
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases
COMPLETED · NA
Explore more on PlainTrial
Metastatic Malignant Neoplasm in the Brain
All registered trials for this condition
Radiation Therapy Recipient
All registered trials for this condition
Texas
All trials with a study site in Texas
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.